Skip to main content
PMC home page
Microbiological Reviews logoLink to Microbiological Reviews
. 1996 Jun;60(2):267–279. doi: 10.1128/mr.60.2.267-279.1996

Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

T F Murphy 1
PMCID: PMC239443  PMID: 8801433

Abstract

Over the past decade, Branhamella catarrhalis has emerged as an important human pathogen. The bacterium is a common cause of otitis media in children and of lower respiratory tract infections in adults with chronic obstructive pulmonary disease. B. catarrhalis is exclusively a human pathogen. It colonizes the respiratory tract of a small proportion of adults and a larger proportion of children. Studies involving restriction enzyme analysis of genomic DNA show that colonization is a dynamic process, with the human host eliminating and acquiring new strains frequently. The surface of B. catarrhalis contains outer membrane proteins, lipooligosaccharide, and pili. The genes which encode several outer membrane proteins have been cloned, and some of these proteins are being studied as potential vaccine antigens. Analysis of the immune response has been limited by the lack of an adequate animal model of B. catarrhalis infection. New information regarding outer membrane structure should guide studies of the human immune response to B. catarrhalis. Immunoassays which specifically detect antibodies to determinants exposed on the bacterial surface will elucidate the most relevant immune response. The recognition of B. catarrhalis as an important human pathogen has stimulated research on the epidemiology and surface structures of the bacterium. Future studies to understand the mechanisms of infection and to elucidate the human immune response to infection hold promise of developing new methods to treat and prevent infections caused by B. catarrhalis.

Full Text

The Full Text of this article is available as a PDF (619.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmad F., McLeod D. T., Power J. T., Calder M. A. Branhamella catarrhalis prevalence in a hospital population. J Hosp Infect. 1985 Mar;6(1):71–74. doi: 10.1016/s0195-6701(85)80020-7. [DOI] [PubMed] [Google Scholar]
  2. Ahmed K. Fimbriae of Branhamella catarrhalis as possible mediators of adherence to pharyngeal epithelial cells. APMIS. 1992 Dec;100(12):1066–1072. doi: 10.1111/j.1699-0463.1992.tb04042.x. [DOI] [PubMed] [Google Scholar]
  3. Ahmed K., Masaki H., Dai T. C., Ichinose A., Utsunomiya Y., Tao M., Nagatake T., Matsumoto K. Expression of fimbriae and host response in Branhamella catarrhalis respiratory infections. Microbiol Immunol. 1994;38(10):767–771. doi: 10.1111/j.1348-0421.1994.tb01855.x. [DOI] [PubMed] [Google Scholar]
  4. Ahmed K., Rikitomi N., Ichinose A., Matsumoto K. Possible presence of a capsule in Branhamella catarrhalis. Microbiol Immunol. 1991;35(5):361–366. doi: 10.1111/j.1348-0421.1991.tb01566.x. [DOI] [PubMed] [Google Scholar]
  5. Ahmed K., Rikitomi N., Matsumoto K. Fimbriation, hemagglutination and adherence properties of fresh clinical isolates of Branhamella catarrhalis. Microbiol Immunol. 1992;36(10):1009–1017. doi: 10.1111/j.1348-0421.1992.tb02105.x. [DOI] [PubMed] [Google Scholar]
  6. Ahmed K., Rikitomi N., Nagatake T., Matsumoto K. Electron microscopic observation of Branhamella catarrhalis. Microbiol Immunol. 1990;34(12):967–975. doi: 10.1111/j.1348-0421.1990.tb01518.x. [DOI] [PubMed] [Google Scholar]
  7. Aitken J. M., Thornley P. E. Isolation of Branhamella catarrhalis from sputum and tracheal aspirate. J Clin Microbiol. 1983 Nov;18(5):1262–1263. doi: 10.1128/jcm.18.5.1262-1263.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Alaeus A., Stiernstedt G. Branhamella catarrhalis septicemia in an immunocompetent adult. Scand J Infect Dis. 1991;23(1):115–116. doi: 10.3109/00365549109023384. [DOI] [PubMed] [Google Scholar]
  9. Aniansson G., Alm B., Andersson B., Larsson P., Nylén O., Peterson H., Rignér P., Svanborg M., Svanborg C. Nasopharyngeal colonization during the first year of life. J Infect Dis. 1992 Jun;165 (Suppl 1):S38–S42. doi: 10.1093/infdis/165-supplement_1-s38. [DOI] [PubMed] [Google Scholar]
  10. Aspin M. M., Hoberman A., McCarty J., McLinn S. E., Aronoff S., Lang D. J., Arrieta A. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr. 1994 Jul;125(1):136–141. doi: 10.1016/s0022-3476(94)70140-7. [DOI] [PubMed] [Google Scholar]
  11. Barenkamp S. J. Protection by serum antibodies in experimental nontypable Haemophilus influenzae otitis media. Infect Immun. 1986 May;52(2):572–578. doi: 10.1128/iai.52.2.572-578.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Bartos L. C., Murphy T. F. Comparison of the outer membrane proteins of 50 strains of Branhamella catarrhalis. J Infect Dis. 1988 Oct;158(4):761–765. doi: 10.1093/infdis/158.4.761. [DOI] [PubMed] [Google Scholar]
  13. Beaulieu D., Scriver S., Bergeron M. G., Low D. E., Parr T. R., Jr, Patterson J. E., Matlow A., Roy P. H. Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol. 1993 Mar;31(3):736–739. doi: 10.1128/jcm.31.3.736-739.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Beucher M., Sparling P. F. Cloning, sequencing, and characterization of the gene encoding FrpB, a major iron-regulated, outer membrane protein of Neisseria gonorrhoeae. J Bacteriol. 1995 Apr;177(8):2041–2049. doi: 10.1128/jb.177.8.2041-2049.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Bhushan R., Craigie R., Murphy T. F. Molecular cloning and characterization of outer membrane protein E of Moraxella (Branhamella) catarrhalis. J Bacteriol. 1994 Nov;176(21):6636–6643. doi: 10.1128/jb.176.21.6636-6643.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Black A. J., Wilson T. S. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J Clin Pathol. 1988 Mar;41(3):329–333. doi: 10.1136/jcp.41.3.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Boyle F. M., Georghiou P. R., Tilse M. H., McCormack J. G. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med J Aust. 1991 May 6;154(9):592–596. doi: 10.5694/j.1326-5377.1991.tb121219.x. [DOI] [PubMed] [Google Scholar]
  18. Brorson J. E., Axelsson A., Holm S. E. Studies on Branhamella Catarrhalis (Neisseria catarrhalis) with special reference to maxillary sinusitis. Scand J Infect Dis. 1976;8(3):151–155. doi: 10.3109/inf.1976.8.issue-3.05. [DOI] [PubMed] [Google Scholar]
  19. Brunham R. C., Plummer F. A., Stephens R. S. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun. 1993 Jun;61(6):2273–2276. doi: 10.1128/iai.61.6.2273-2276.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Burman L. A., Leinonen M., Trollfors B. Use of serology to diagnose pneumonia caused by nonencapsulated Haemophilus influenzae and Moraxella catarrhalis. J Infect Dis. 1994 Jul;170(1):220–222. doi: 10.1093/infdis/170.1.220. [DOI] [PubMed] [Google Scholar]
  21. Campagnari A. A., Gupta M. R., Dudas K. C., Murphy T. F., Apicella M. A. Antigenic diversity of lipooligosaccharides of nontypable Haemophilus influenzae. Infect Immun. 1987 Apr;55(4):882–887. doi: 10.1128/iai.55.4.882-887.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Campagnari A. A., Shanks K. L., Dyer D. W. Growth of Moraxella catarrhalis with human transferrin and lactoferrin: expression of iron-repressible proteins without siderophore production. Infect Immun. 1994 Nov;62(11):4909–4914. doi: 10.1128/iai.62.11.4909-4914.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Campagnari A. A., Spinola S. M., Lesse A. J., Kwaik Y. A., Mandrell R. E., Apicella M. A. Lipooligosaccharide epitopes shared among gram-negative non-enteric mucosal pathogens. Microb Pathog. 1990 May;8(5):353–362. doi: 10.1016/0882-4010(90)90094-7. [DOI] [PubMed] [Google Scholar]
  24. Carson R. T., McDonald D. F., Kehoe M. A., Calvert J. E. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane proteins of Moraxella catarrhalis. Immunology. 1994 Sep;83(1):107–113. [PMC free article] [PubMed] [Google Scholar]
  25. Catlin B. W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev. 1990 Oct;3(4):293–320. doi: 10.1128/cmr.3.4.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Chapman A. J., Jr, Musher D. M., Jonsson S., Clarridge J. E., Wallace R. J., Jr Development of bactericidal antibody during Branhamella catarrhalis infection. J Infect Dis. 1985 May;151(5):878–882. doi: 10.1093/infdis/151.5.878. [DOI] [PubMed] [Google Scholar]
  27. Chonmaitree T., Owen M. J., Patel J. A., Hedgpeth D., Horlick D., Howie V. M. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr. 1992 Jun;120(6):856–862. doi: 10.1016/s0022-3476(05)81950-x. [DOI] [PubMed] [Google Scholar]
  28. Choo P. W., Gantz N. M. Branhamella catarrhalis pneumonia with bacteremia. South Med J. 1989 Oct;82(10):1317–1318. doi: 10.1097/00007611-198910000-00035. [DOI] [PubMed] [Google Scholar]
  29. Chung M. H., Enrique R., Lim D. J., De Maria T. F. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol. 1994 Jul;114(4):415–422. doi: 10.3109/00016489409126080. [DOI] [PubMed] [Google Scholar]
  30. Cimolai N., Adderley R. J. Branhamella catarrhalis bacteremia in children. Acta Paediatr Scand. 1989 May;78(3):465–468. doi: 10.1111/j.1651-2227.1989.tb11113.x. [DOI] [PubMed] [Google Scholar]
  31. Collazos J., de Miguel J., Ayarza R. Moraxella catarrhalis bacteremic pneumonia in adults: two cases and review of the literature. Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):237–240. doi: 10.1007/BF02098086. [DOI] [PubMed] [Google Scholar]
  32. Contreras M. R., Ash S. R., Swick S. D., Grutzner J. Peritonitis due to Moraxella (Branhamella) catarrhalis in a diabetic patient receiving peritoneal dialysis. South Med J. 1993 May;86(5):589–590. doi: 10.1097/00007611-199305000-00023. [DOI] [PubMed] [Google Scholar]
  33. Cook P. P., Hecht D. W., Snydman D. R. Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease. J Hosp Infect. 1989 Apr;13(3):299–307. doi: 10.1016/0195-6701(89)90011-x. [DOI] [PubMed] [Google Scholar]
  34. Cooke R. P., Williams R., Bannister C. M. Shunt-associated ventriculitis caused by Branhamella catarrhalis. J Hosp Infect. 1990 Feb;15(2):197–198. doi: 10.1016/0195-6701(90)90133-9. [DOI] [PubMed] [Google Scholar]
  35. Craig D. B., Wehrle P. A. Branhamella catarrhalis septic arthritis. J Rheumatol. 1983 Dec;10(6):985–986. [PubMed] [Google Scholar]
  36. Davies B. I., Maesen F. P. Epidemiological and bacteriological findings on Branhamella catarrhalis respiratory infections in The Netherlands. Drugs. 1986;31 (Suppl 3):28–33. doi: 10.2165/00003495-198600313-00008. [DOI] [PubMed] [Google Scholar]
  37. Del Beccaro M. A., Mendelman P. M., Inglis A. F., Richardson M. A., Duncan N. O., Clausen C. R., Stull T. L. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992 Jan;120(1):81–84. doi: 10.1016/s0022-3476(05)80605-5. [DOI] [PubMed] [Google Scholar]
  38. Denamur E., Picard-Pasquier N., Mura C., Picard B., Orfila J., Krishnamoorthy R. Comparison of molecular epidemiological tools for Branhamella catarrhalis typing. Res Microbiol. 1991 Jun;142(5):585–589. doi: 10.1016/0923-2508(91)90191-c. [DOI] [PubMed] [Google Scholar]
  39. Dickinson D. P., Loos B. G., Dryja D. M., Bernstein J. M. Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis. 1988 Jul;158(1):205–208. doi: 10.1093/infdis/158.1.205. [DOI] [PubMed] [Google Scholar]
  40. Doern G. V., Gantz N. M. Isolation of Branhamella (Neisseria) catarrhalis from men with urethritis. Sex Transm Dis. 1982 Oct-Dec;9(4):202–204. doi: 10.1097/00007435-198210000-00008. [DOI] [PubMed] [Google Scholar]
  41. Doern G. V., Miller M. J., Winn R. E. Branhamella (Neisseria) catarrhalis systemic disease in humans. Case reports and review of the literature. Arch Intern Med. 1981 Nov;141(12):1690–1692. [PubMed] [Google Scholar]
  42. Douer D., Danziger Y., Pinkhas J. Neisseria catarrhalis endocarditis. Ann Intern Med. 1977 Jan;86(1):116–116. doi: 10.7326/0003-4819-86-1-116_1. [DOI] [PubMed] [Google Scholar]
  43. Doyle W. J. Animal models of otitis media: other pathogens. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S45–S47. [PubMed] [Google Scholar]
  44. Dyson C., Poonyth H. D., Watkinson M., Rose S. J. Life threatening Branhamella catarrhalis pneumonia in young infants. J Infect. 1990 Nov;21(3):305–307. doi: 10.1016/0163-4453(90)94101-5. [DOI] [PubMed] [Google Scholar]
  45. Edebrink P., Jansson P. E., Rahman M. M., Widmalm G., Holme T., Rahman M., Weintraub A. Structural studies of the O-polysaccharide from the lipopolysaccharide of Moraxella (Branhamella) catarrhalis serotype A (strain ATCC 25238). Carbohydr Res. 1994 May 5;257(2):269–284. doi: 10.1016/0008-6215(94)80040-5. [DOI] [PubMed] [Google Scholar]
  46. Ejlertsen T., Thisted E., Ebbesen F., Olesen B., Renneberg J. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect. 1994 Jul;29(1):23–31. doi: 10.1016/s0163-4453(94)94979-4. [DOI] [PubMed] [Google Scholar]
  47. Eliasson I. Serological identification of Branhamella catarrhalis. Serological evidence for infection. Drugs. 1986;31 (Suppl 3):7–10. doi: 10.2165/00003495-198600313-00004. [DOI] [PubMed] [Google Scholar]
  48. Engleberg N. C., Pearlman E., Eisenstein B. I. Legionella pneumophila surface antigens cloned and expressed in Escherichia coli are translocated to the host cell surface and interact with specific anti-Legionella antibodies. J Bacteriol. 1984 Oct;160(1):199–203. doi: 10.1128/jb.160.1.199-203.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Faden H., Bernstein J., Brodsky L., Stanievich J., Krystofik D., Shuff C., Hong J. J., Ogra P. L. Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis. 1989 Dec;160(6):999–1004. doi: 10.1093/infdis/160.6.999. [DOI] [PubMed] [Google Scholar]
  50. Faden H., Bernstein J., Brodsky L., Stanievich J., Ogra P. L. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol. 1992 Jan;101(1):87–91. doi: 10.1177/000348949210100119. [DOI] [PubMed] [Google Scholar]
  51. Faden H., Harabuchi Y., Hong J. J. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis. 1994 Jun;169(6):1312–1317. doi: 10.1093/infdis/169.6.1312. [DOI] [PubMed] [Google Scholar]
  52. Faden H., Hong J. J., Pahade N. Immune response to Moraxella catarrhalis in children with otitis media: opsonophagocytosis with antigen-coated latex beads. Ann Otol Rhinol Laryngol. 1994 Jul;103(7):522–524. doi: 10.1177/000348949410300704. [DOI] [PubMed] [Google Scholar]
  53. Faden H., Hong J., Murphy T. Immune response to outer membrane antigens of Moraxella catarrhalis in children with otitis media. Infect Immun. 1992 Sep;60(9):3824–3829. doi: 10.1128/iai.60.9.3824-3829.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Faden H., Waz M. J., Bernstein J. M., Brodsky L., Stanievich J., Ogra P. L. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol. 1991 Aug;100(8):612–615. doi: 10.1177/000348949110000802. [DOI] [PubMed] [Google Scholar]
  55. Fomsgaard J. S., Fomsgaard A., Høiby N., Bruun B., Galanos C. Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains. Infect Immun. 1991 Sep;59(9):3346–3349. doi: 10.1128/iai.59.9.3346-3349.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Forsgren A., Penta A., Schlossman S. F., Tedder T. F. Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens. Cell Immunol. 1988 Mar;112(1):78–88. doi: 10.1016/0008-8749(88)90277-8. [DOI] [PubMed] [Google Scholar]
  57. Gan V. N., Kusmiesz H., Shelton S., Nelson J. D. Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media. Antimicrob Agents Chemother. 1991 May;35(5):967–971. doi: 10.1128/aac.35.5.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Gehanno P., Berche P., Boucot I., Lambert-Zechovsky N., Bingen E., Gres J. J., Rollin C. Comparative efficacy and safety of cefprozil and amoxycillin/clavulanate in the treatment of acute otitis media in children. J Antimicrob Chemother. 1994 Jun;33(6):1209–1218. doi: 10.1093/jac/33.6.1209. [DOI] [PubMed] [Google Scholar]
  59. Giebink G. S., Berzins I. K., Marker S. C., Schiffman G. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect Immun. 1980 Nov;30(2):445–450. doi: 10.1128/iai.30.2.445-450.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Giebink G. S., Berzins I. K., Schiffman G., Quie P. G. Experimental otitis media in chinchillas following nasal colonization with type 7F Streptococcus pneumoniae: prevention after vaccination with pneumococcal capsular polysaccharide. J Infect Dis. 1979 Nov;140(5):716–723. doi: 10.1093/infdis/140.5.716. [DOI] [PubMed] [Google Scholar]
  61. Gilleland H. E., Jr, Gilleland L. B., Matthews-Greer J. M. Outer membrane protein F preparation of Pseudomonas aeruginosa as a vaccine against chronic pulmonary infection with heterologous immunotype strains in a rat model. Infect Immun. 1988 May;56(5):1017–1022. doi: 10.1128/iai.56.5.1017-1022.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Gilleland H. E., Jr, Parker M. G., Matthews J. M., Berg R. D. Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun. 1984 Apr;44(1):49–54. doi: 10.1128/iai.44.1.49-54.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Goldblatt D., Scadding G. K., Lund V. J., Wade A. M., Turner M. W., Pandey J. P. Association of Gm allotypes with the antibody response to the outer membrane proteins of a common upper respiratory tract organism, Moraxella catarrhalis. J Immunol. 1994 Dec 1;153(11):5316–5320. [PubMed] [Google Scholar]
  64. Goldblatt D., Turner M. W., Levinsky R. J. Branhamella catarrhalis: antigenic determinants and the development of the IgG subclass response in childhood. J Infect Dis. 1990 Nov;162(5):1128–1135. doi: 10.1093/infdis/162.5.1128. [DOI] [PubMed] [Google Scholar]
  65. Goldschneider I., Gotschlich E. C., Artenstein M. S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med. 1969 Jun 1;129(6):1307–1326. doi: 10.1084/jem.129.6.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Gray L. D., Van Scoy R. E., Anhalt J. P., Yu P. K. Wound infection caused by Branhamella catarrhalis. J Clin Microbiol. 1989 May;27(5):818–820. doi: 10.1128/jcm.27.5.818-820.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Green B. A., Vazquez M. E., Zlotnick G. W., Quigley-Reape G., Swarts J. D., Green I., Cowell J. L., Bluestone C. D., Doyle W. J. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model. Infect Immun. 1993 May;61(5):1950–1957. doi: 10.1128/iai.61.5.1950-1957.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Gulig P. A., McCracken G. H., Jr, Frisch C. F., Johnston K. H., Hansen E. J. Antibody response of infants to cell surface-exposed outer membrane proteins of Haemophilus influenzae type b after systemic Haemophilus disease. Infect Immun. 1982 Jul;37(1):82–88. doi: 10.1128/iai.37.1.82-88.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Guthrie R., Bakenhaster K., Nelson R., Woskobnick R. Branhamella catarrhalis sepsis: a case report and review of the literature. J Infect Dis. 1988 Oct;158(4):907–908. doi: 10.1093/infdis/158.4.907. [DOI] [PubMed] [Google Scholar]
  70. Haase E. M., Campagnari A. A., Sarwar J., Shero M., Wirth M., Cumming C. U., Murphy T. F. Strain-specific and immunodominant surface epitopes of the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1991 Apr;59(4):1278–1284. doi: 10.1128/iai.59.4.1278-1284.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Haase E. M., Yi K., Morse G. D., Murphy T. F. Mapping of bactericidal epitopes on the P2 porin protein of nontypeable Haemophilus influenzae. Infect Immun. 1994 Sep;62(9):3712–3722. doi: 10.1128/iai.62.9.3712-3722.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Haddad J., Le Faou A., Simeoni U., Messer J. Hospital-acquired bronchopulmonary infection in premature infants due to Branhamella catarrhalis. J Hosp Infect. 1986 May;7(3):301–302. doi: 10.1016/0195-6701(86)90085-x. [DOI] [PubMed] [Google Scholar]
  73. Hager H., Verghese A., Alvarez S., Berk S. L. Branhamella catarrhalis respiratory infections. Rev Infect Dis. 1987 Nov-Dec;9(6):1140–1149. doi: 10.1093/clinids/9.6.1140. [DOI] [PubMed] [Google Scholar]
  74. Harkness R. E., Guimond M. J., McBey B. A., Klein M. H., Percy D. H., Croy B. A. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. Brief report. APMIS. 1993 Oct;101(10):805–810. [PubMed] [Google Scholar]
  75. Hellio R., Guibourdenche M., Collatz E., Riou J. Y. The envelope structure of Branhamella catarrhalis as studied by transmission electron microscopy. Ann Inst Pasteur Microbiol. 1988 Sep-Oct;139(5):515–525. doi: 10.1016/0769-2609(88)90151-2. [DOI] [PubMed] [Google Scholar]
  76. Helminen M. E., Maciver I., Latimer J. L., Cope L. D., McCracken G. H., Jr, Hansen E. J. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect Immun. 1993 May;61(5):2003–2010. doi: 10.1128/iai.61.5.2003-2010.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Helminen M. E., Maciver I., Latimer J. L., Klesney-Tait J., Cope L. D., Paris M., McCracken G. H., Jr, Hansen E. J. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J Infect Dis. 1994 Oct;170(4):867–872. doi: 10.1093/infdis/170.4.867. [DOI] [PubMed] [Google Scholar]
  78. Helminen M. E., Maciver I., Paris M., Latimer J. L., Lumbley S. L., Cope L. D., McCracken G. H., Jr, Hansen E. J. A mutation affecting expression of a major outer membrane protein of Moraxella catarrhalis alters serum resistance and survival in vivo. J Infect Dis. 1993 Nov;168(5):1194–1201. doi: 10.1093/infdis/168.5.1194. [DOI] [PubMed] [Google Scholar]
  79. Hol C., Verduin C. M., van Dijke E., Verhoef J., van Dijk H. Complement resistance in Branhamella (Moraxella) catarrhalis. Lancet. 1993 May 15;341(8855):1281–1281. doi: 10.1016/0140-6736(93)91185-o. [DOI] [PubMed] [Google Scholar]
  80. Hsiao C. B., Sethi S., Murphy T. F. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb Pathog. 1995 Oct;19(4):215–225. doi: 10.1016/s0882-4010(95)90272-4. [DOI] [PubMed] [Google Scholar]
  81. Ikram R. B., Nixon M., Aitken J., Wells E. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J Hosp Infect. 1993 Sep;25(1):7–14. doi: 10.1016/0195-6701(93)90004-j. [DOI] [PubMed] [Google Scholar]
  82. Ioannidis J. P., Worthington M., Griffiths J. K., Snydman D. R. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis. 1995 Aug;21(2):390–397. doi: 10.1093/clinids/21.2.390. [DOI] [PubMed] [Google Scholar]
  83. Jeanteur D., Lakey J. H., Pattus F. The bacterial porin superfamily: sequence alignment and structure prediction. Mol Microbiol. 1991 Sep;5(9):2153–2164. doi: 10.1111/j.1365-2958.1991.tb02145.x. [DOI] [PubMed] [Google Scholar]
  84. Johnson C. E., Carlin S. A., Super D. M., Rehmus J. M., Roberts D. G., Christopher N. C., Whitwell J. K., Shurin P. A. Cefixime compared with amoxicillin for treatment of acute otitis media. J Pediatr. 1991 Jul;119(1 Pt 1):117–122. doi: 10.1016/s0022-3476(05)81051-0. [DOI] [PubMed] [Google Scholar]
  85. Jordan K. L., Berk S. H., Berk S. L. A comparison of serum bactericidal activity and phenotypic characteristics of bacteremic, pneumonia-causing strains, and colonizing strains of Branhamella catarrhalis. Am J Med. 1990 May 14;88(5A):28S–32S. doi: 10.1016/0002-9343(90)90258-f. [DOI] [PubMed] [Google Scholar]
  86. Jousimies-Somer H. R., Savolainen S., Ylikoski J. S. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J Clin Microbiol. 1989 Dec;27(12):2736–2743. doi: 10.1128/jcm.27.12.2736-2743.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Jönsson I., Holme T., Krook A., Thorén M. Serological cross-reactions between Moraxella (Branhamella) catarrhalis and other oropharyngeal bacteria. Eur J Clin Microbiol Infect Dis. 1993 Apr;12(4):289–293. doi: 10.1007/BF01967261. [DOI] [PubMed] [Google Scholar]
  88. Karjalainen H., Koskela M., Luotonen J., Herva E., Sipilä P. Occurrences of antibodies against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion and serum during the course of acute otitis media. Acta Otolaryngol. 1991;111(1):112–119. doi: 10.3109/00016489109137361. [DOI] [PubMed] [Google Scholar]
  89. Karjalainen H., Koskela M., Luotonen J., Sipilä P. Secretory antibodies specific to Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis in middle ear effusion during acute otitis media. Acta Otolaryngol. 1991;111(3):524–529. doi: 10.3109/00016489109138378. [DOI] [PubMed] [Google Scholar]
  90. Kawakami Y., Segawa K., Kanai M. A case of acute catarrhal conjunctivitis due to Branhamella catarrhalis. Microbiol Immunol. 1983;27(7):641–643. doi: 10.1111/j.1348-0421.1983.tb00626.x. [DOI] [PubMed] [Google Scholar]
  91. Kawakami Y., Ueno I., Katsuyama T., Furihata K., Matsumoto H. Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol. 1994;38(11):891–895. doi: 10.1111/j.1348-0421.1994.tb02142.x. [DOI] [PubMed] [Google Scholar]
  92. Klein J. O. Otitis media. Clin Infect Dis. 1994 Nov;19(5):823–833. doi: 10.1093/clinids/19.5.823. [DOI] [PubMed] [Google Scholar]
  93. Klingman K. L., Murphy T. F. Purification and characterization of a high-molecular-weight outer membrane protein of Moraxella (Branhamella) catarrhalis. Infect Immun. 1994 Apr;62(4):1150–1155. doi: 10.1128/iai.62.4.1150-1155.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Klingman K. L., Pye A., Murphy T. F., Hill S. L. Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am J Respir Crit Care Med. 1995 Sep;152(3):1072–1078. doi: 10.1164/ajrccm.152.3.7663786. [DOI] [PubMed] [Google Scholar]
  95. Korppi M., Katila M. L., Jäskeläinen J., Leinonen M. Role of Moraxella (Branhamella) catarrhalis as a respiratory pathogen in children. Acta Paediatr. 1992 Dec;81(12):993–996. doi: 10.1111/j.1651-2227.1992.tb12161.x. [DOI] [PubMed] [Google Scholar]
  96. Kostiala A. A., Honkanen T. Branhamella catarrhalis as a cause of acute purulent pericarditis. J Infect. 1989 Nov;19(3):291–292. doi: 10.1016/s0163-4453(89)90949-3. [DOI] [PubMed] [Google Scholar]
  97. LANCEFIELD R. C. Current knowledge of type-specific M antigens of group A streptococci. J Immunol. 1962 Sep;89:307–313. [PubMed] [Google Scholar]
  98. Leach A. J., Boswell J. B., Asche V., Nienhuys T. G., Mathews J. D. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J. 1994 Nov;13(11):983–989. doi: 10.1097/00006454-199411000-00009. [DOI] [PubMed] [Google Scholar]
  99. Leinonen M., Luotonen J., Herva E., Valkonen K., Mäkelä P. H. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis. 1981 Dec;144(6):570–574. doi: 10.1093/infdis/144.6.570. [DOI] [PubMed] [Google Scholar]
  100. Loeb M. R. Immunoblot method for identifying surface components, determining their cross-reactivity, and investigating cell topology: results with Haemophilus influenzae type b. Anal Biochem. 1984 Nov 15;143(1):196–204. doi: 10.1016/0003-2697(84)90576-1. [DOI] [PubMed] [Google Scholar]
  101. Loeb M. R., Woodin K. A. Cross-reactivity of surface-exposed epitopes of outer membrane antigens of Haemophilus influenzae type b. Infect Immun. 1987 Dec;55(12):2977–2983. doi: 10.1128/iai.55.12.2977-2983.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Lue Y. A., Simms D. H., Ubriani R., Pfeiffer N. C., Gromisch D. S. Ophthalmia neonatorum caused by penicillin-resistant Branhamella Catarrhalis. N Y State J Med. 1981 Nov;81(12):1775–1776. [PubMed] [Google Scholar]
  103. Lundgren K., Ingvarsson L. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy. Drugs. 1986;31 (Suppl 3):125–131. doi: 10.2165/00003495-198600313-00028. [DOI] [PubMed] [Google Scholar]
  104. Maciver I., Unhanand M., McCracken G. H., Jr, Hansen E. J. Effect of immunization of pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1993 Aug;168(2):469–472. doi: 10.1093/infdis/168.2.469. [DOI] [PubMed] [Google Scholar]
  105. Marrs C. F., Weir S. Pili (fimbriae) of Branhamella species. Am J Med. 1990 May 14;88(5A):36S–40S. doi: 10.1016/0002-9343(90)90260-k. [DOI] [PubMed] [Google Scholar]
  106. Maslow J. N., Mulligan M. E., Arbeit R. D. Molecular epidemiology: application of contemporary techniques to the typing of microorganisms. Clin Infect Dis. 1993 Aug;17(2):153–164. doi: 10.1093/clinids/17.2.153. [DOI] [PubMed] [Google Scholar]
  107. Masoud H., Perry M. B., Richards J. C. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur J Biochem. 1994 Feb 15;220(1):209–216. doi: 10.1111/j.1432-1033.1994.tb18616.x. [DOI] [PubMed] [Google Scholar]
  108. Matthews-Greer J. M., Gilleland H. E., Jr Outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine against heterologous immunotype strains in a burned mouse model. J Infect Dis. 1987 Jun;155(6):1282–1291. doi: 10.1093/infdis/155.6.1282. [DOI] [PubMed] [Google Scholar]
  109. McKenzie H., Morgan M. G., Jordens J. Z., Enright M. C., Bain M. Characterisation of hospital isolates of Moraxella (Branhamella) catarrhalis by SDS-PAGE of whole-cell proteins, immunoblotting and restriction-endonuclease analysis. J Med Microbiol. 1992 Jul;37(1):70–76. doi: 10.1099/00222615-37-1-70. [DOI] [PubMed] [Google Scholar]
  110. McLeod D. T., Ahmad F., Capewell S., Croughan M. J., Calder M. A., Seaton A. Increase in bronchopulmonary infection due to branhamella catarrhalis. Br Med J (Clin Res Ed) 1986 Apr 26;292(6528):1103–1105. doi: 10.1136/bmj.292.6528.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Melendez P. R., Johnson R. H. Bacteremia and septic arthritis caused by Moraxella catarrhalis. Rev Infect Dis. 1991 May-Jun;13(3):428–429. doi: 10.1093/clinids/13.3.428. [DOI] [PubMed] [Google Scholar]
  112. Morgan M. G., McKenzie H., Enright M. C., Bain M., Emmanuel F. X. Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):305–312. doi: 10.1007/BF01962069. [DOI] [PubMed] [Google Scholar]
  113. Murphy T. F., Bartos L. C. Surface-exposed and antigenically conserved determinants of outer membrane proteins of Branhamella catarrhalis. Infect Immun. 1989 Oct;57(10):2938–2941. doi: 10.1128/iai.57.10.2938-2941.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Murphy T. F., Kirkham C., Lesse A. J. The major heat-modifiable outer membrane protein CD is highly conserved among strains of Branhamella catarrhalis. Mol Microbiol. 1993 Oct;10(1):87–97. doi: 10.1111/j.1365-2958.1993.tb00906.x. [DOI] [PubMed] [Google Scholar]
  115. Murphy T. F., Loeb M. R. Isolation of the outer membrane of Branhamella catarrhalis. Microb Pathog. 1989 Mar;6(3):159–174. doi: 10.1016/0882-4010(89)90066-1. [DOI] [PubMed] [Google Scholar]
  116. Murphy T. F., Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Oct;146(4):1067–1083. doi: 10.1164/ajrccm/146.4.1067. [DOI] [PubMed] [Google Scholar]
  117. Nicotra B., Rivera M., Luman J. I., Wallace R. J., Jr Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. Arch Intern Med. 1986 May;146(5):890–893. [PubMed] [Google Scholar]
  118. Nikaido H., Saier M. H., Jr Transport proteins in bacteria: common themes in their design. Science. 1992 Nov 6;258(5084):936–942. doi: 10.1126/science.1279804. [DOI] [PubMed] [Google Scholar]
  119. Ninane G., Joly J., Kraytman M. Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture. Br Med J. 1978 Feb 4;1(6108):276–278. doi: 10.1136/bmj.1.6108.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Noel G. J., Barenkamp S. J., St Geme J. W., 3rd, Haining W. N., Mosser D. M. High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages. J Infect Dis. 1994 Feb;169(2):425–429. doi: 10.1093/infdis/169.2.425. [DOI] [PubMed] [Google Scholar]
  121. Onofrio J. M., Shulkin A. N., Heidbrink P. J., Toews G. B., Pierce A. K. Pulmonary clearance and phagocytic cell response to normal pharyngeal flora. Am Rev Respir Dis. 1981 Feb;123(2):222–225. doi: 10.1164/arrd.1981.123.2.222. [DOI] [PubMed] [Google Scholar]
  122. Owen M. J., Anwar R., Nguyen H. K., Swank P. R., Bannister E. R., Howie V. M. Efficacy of cefixime in the treatment of acute otitis media in children. Am J Dis Child. 1993 Jan;147(1):81–86. doi: 10.1001/archpedi.1993.02160250083027. [DOI] [PubMed] [Google Scholar]
  123. Patterson J. E., Patterson T. F., Farrel P., Hierholzer W. J., Jr, Zervos M. J. Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol. 1989 May;27(5):944–946. doi: 10.1128/jcm.27.5.944-946.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Patterson T. F., Patterson J. E., Masecar B. L., Barden G. E., Hierholzer W. J., Jr, Zervos M. J. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis. 1988 May;157(5):996–1001. doi: 10.1093/infdis/157.5.996. [DOI] [PubMed] [Google Scholar]
  125. Picard B., Goullet P., Denamur E., Suermondt G. Esterase electrophoresis: a molecular tool for studying the epidemiology of Branhamella catarrhalis nosocomial infection. Epidemiol Infect. 1989 Dec;103(3):547–554. doi: 10.1017/s0950268800030946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Pollard J. A., Wallace R. J., Jr, Nash D. R., Luman J. I., Wilson R. W. Incidence of Branhamella catarrhalis in the sputa of patients with chronic lung disease. Drugs. 1986;31 (Suppl 3):103–108. doi: 10.2165/00003495-198600313-00022. [DOI] [PubMed] [Google Scholar]
  127. Post J. C., Preston R. A., Aul J. J., Larkins-Pettigrew M., Rydquist-White J., Anderson K. W., Wadowsky R. M., Reagan D. R., Walker E. S., Kingsley L. A. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA. 1995 May 24;273(20):1598–1604. [PubMed] [Google Scholar]
  128. Prallet B., Lucht F., Alexandre C. Vertebral osteomyelitis due to Branhamella catarrhalis. Rev Infect Dis. 1991 Jul-Aug;13(4):769–769. doi: 10.1093/clinids/13.4.769. [DOI] [PubMed] [Google Scholar]
  129. Prellner K., Christensen P., Hovelius B., Rosén C. Nasopharyngeal carriage of bacteria in otitis-prone and non-otitis-prone children in day-care centres. Acta Otolaryngol. 1984 Sep-Oct;98(3-4):343–350. doi: 10.3109/00016488409107572. [DOI] [PubMed] [Google Scholar]
  130. Pukander J. S., Jero J. P., Kaprio E. A., Sorri M. J. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J. 1993 Dec;12(12 Suppl 3):S118–S121. doi: 10.1097/00006454-199312003-00005. [DOI] [PubMed] [Google Scholar]
  131. Relman D. A., Domenighini M., Tuomanen E., Rappuoli R., Falkow S. Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2637–2641. doi: 10.1073/pnas.86.8.2637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Richards S. J., Greening A. P., Enright M. C., Morgan M. G., McKenzie H. Outbreak of Moraxella catarrhalis in a respiratory unit. Thorax. 1993 Jan;48(1):91–92. doi: 10.1136/thx.48.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Rikitomi N., Andersson B., Matsumoto K., Lindstedt R., Svanborg C. Mechanism of adherence of Moraxella (Branhamella) catarrhalis. Scand J Infect Dis. 1991;23(5):559–567. doi: 10.3109/00365549109105178. [DOI] [PubMed] [Google Scholar]
  134. Roberts M. C., Pang Y. J., Spencer R. C., Winstanley T. G., Brown B. A., Wallace R. J., Jr Tetracycline resistance in Moraxella (Branhamella) catarrhalis: demonstration of two clonal outbreaks by using pulsed-field gel electrophoresis. Antimicrob Agents Chemother. 1991 Nov;35(11):2453–2455. doi: 10.1128/aac.35.11.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Rotta A. T., Asmar B. I. Moraxella catarrhalis bacteremia and preseptal cellulitis. South Med J. 1994 Apr;87(4):541–542. doi: 10.1097/00007611-199404000-00025. [DOI] [PubMed] [Google Scholar]
  136. Ruuskanen O., Heikkinen T. Otitis media: etiology and diagnosis. Pediatr Infect Dis J. 1994 Jan;13(1 Suppl 1):S23–S54. [PubMed] [Google Scholar]
  137. Saito H., Anaissie E. J., Khardori N., Bodey G. P. Branhamella catarrhalis septicemia in patients with leukemia. Cancer. 1988 Jun 1;61(11):2315–2317. doi: 10.1002/1097-0142(19880601)61:11<2315::aid-cncr2820611128>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]
  138. Sanyal S. K., Wilson N., Twum-Danso K., Abomelha A., Sohel S. Moraxella endocarditis following balloon angioplasty of aortic coarctation. Am Heart J. 1990 Jun;119(6):1421–1423. doi: 10.1016/s0002-8703(05)80199-1. [DOI] [PubMed] [Google Scholar]
  139. Sarwar J., Campagnari A. A., Kirkham C., Murphy T. F. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect Immun. 1992 Mar;60(3):804–809. doi: 10.1128/iai.60.3.804-809.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  140. Sethi S., Hill S. L., Murphy T. F. Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun. 1995 Apr;63(4):1516–1520. doi: 10.1128/iai.63.4.1516-1520.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Shurin P. A., Pelton S. I., Tager I. B., Kasper D. L. Bactericidal antibody and susceptibility to otitis media caused by nontypable strains of Haemophilus influenzae. J Pediatr. 1980 Sep;97(3):364–369. doi: 10.1016/s0022-3476(80)80182-x. [DOI] [PubMed] [Google Scholar]
  142. Shurin P. A., Rehmus J. M., Johnson C. E., Marchant C. D., Carlin S. A., Super D. M., Van Hare G. F., Jones P. K., Ambrosino D. M., Siber G. R. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr. 1993 Nov;123(5):801–810. doi: 10.1016/s0022-3476(05)80865-0. [DOI] [PubMed] [Google Scholar]
  143. Smith G. L. Branhamella catarrhalis infection imitating gonorrhea in a man. N Engl J Med. 1987 May 14;316(20):1277–1277. [PubMed] [Google Scholar]
  144. Smith J. M., Lockwood B. M. A 2-year survey of Branhamella catarrhalis in a general hospital. J Hosp Infect. 1986 May;7(3):277–282. doi: 10.1016/0195-6701(86)90078-2. [DOI] [PubMed] [Google Scholar]
  145. Soto-Hernandez J. L., Holtsclaw-Berk S., Harvill L. M., Berk S. L. Phenotypic characteristics of Branhamella catarrhalis strains. J Clin Microbiol. 1989 May;27(5):903–908. doi: 10.1128/jcm.27.5.903-908.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Srikumar R., Dahan D., Gras M. F., Ratcliffe M. J., van Alphen L., Coulton J. W. Antigenic sites on porin of Haemophilus influenzae type b: mapping with synthetic peptides and evaluation of structure predictions. J Bacteriol. 1992 Jun;174(12):4007–4016. doi: 10.1128/jb.174.12.4007-4016.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Srinivasan G., Raff M. J., Templeton W. C., Givens S. J., Graves R. C., Melo J. C. Branhamella catarrhalis pneumonia: report of two cases and review of the literature. Am Rev Respir Dis. 1981 May;123(5):553–555. doi: 10.1164/arrd.1981.123.5.553. [DOI] [PubMed] [Google Scholar]
  148. St Geme J. W., 3rd, Falkow S., Barenkamp S. J. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2875–2879. doi: 10.1073/pnas.90.7.2875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Stenfors L. E., Räisänen S. Abundant attachment of bacteria to nasopharyngeal epithelium in otitis-prone children. J Infect Dis. 1992 Jun;165(6):1148–1150. doi: 10.1093/infdis/165.6.1148. [DOI] [PubMed] [Google Scholar]
  150. Stenfors L. E., Räisänen S. Quantitative analysis of the bacterial findings in otitis media. J Laryngol Otol. 1990 Oct;104(10):749–757. doi: 10.1017/s0022215100113842. [DOI] [PubMed] [Google Scholar]
  151. Stenfors L. E., Räisänen S. Secretory IgA-, IgG- and C3b-coated bacteria in the nasopharynx of otitis-prone and non-otitis-prone children. Acta Otolaryngol. 1993 Mar;113(2):191–195. doi: 10.3109/00016489309135791. [DOI] [PubMed] [Google Scholar]
  152. Stool S. E., Field M. J. The impact of otitis media. Pediatr Infect Dis J. 1989 Jan;8(1 Suppl):S11–S14. [PubMed] [Google Scholar]
  153. Suzuki K., Bakaletz L. O. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect Immun. 1994 May;62(5):1710–1718. doi: 10.1128/iai.62.5.1710-1718.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Tuomanen E., Weiss A. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis. 1985 Jul;152(1):118–125. doi: 10.1093/infdis/152.1.118. [DOI] [PubMed] [Google Scholar]
  155. Ueyama T., Kurono Y., Shirabe K., Takeshita M., Mogi G. High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J Clin Microbiol. 1995 Jul;33(7):1835–1838. doi: 10.1128/jcm.33.7.1835-1838.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  156. Unhanand M., Maciver I., Ramilo O., Arencibia-Mireles O., Argyle J. C., McCracken G. H., Jr, Hansen E. J. Pulmonary clearance of Moraxella catarrhalis in an animal model. J Infect Dis. 1992 Apr;165(4):644–650. doi: 10.1093/infdis/165.4.644. [DOI] [PubMed] [Google Scholar]
  157. Urisu A., Cowell J. L., Manclark C. R. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells. Infect Immun. 1986 Jun;52(3):695–701. doi: 10.1128/iai.52.3.695-701.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Van Hare G. F., Shurin P. A., Marchant C. D., Cartelli N. A., Johnson C. E., Fulton D., Carlin S., Kim C. H. Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis. 1987 Jan-Feb;9(1):16–27. doi: 10.1093/clinids/9.1.16. [DOI] [PubMed] [Google Scholar]
  159. Vaneechoutte M., Verschraegen G., Claeys G., Van Den Abeele A. M. Serological typing of Branhamella catarrhalis strains on the basis of lipopolysaccharide antigens. J Clin Microbiol. 1990 Feb;28(2):182–187. doi: 10.1128/jcm.28.2.182-187.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Vaneechoutte M., Verschraegen G., Claeys G., Weise B., Van den Abeele A. M. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol. 1990 Dec;28(12):2674–2680. doi: 10.1128/jcm.28.12.2674-2680.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Verduin C. M., Jansze M., Hol C., Mollnes T. E., Verhoef J., van Dijk H. Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation. Infect Immun. 1994 Feb;62(2):589–595. doi: 10.1128/iai.62.2.589-595.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Verghese A., Berro E., Berro J., Franzus B. W. Pulmonary clearance and phagocytic cell response in a murine model of Branhamella catarrhalis infection. J Infect Dis. 1990 Nov;162(5):1189–1192. doi: 10.1093/infdis/162.5.1189. [DOI] [PubMed] [Google Scholar]
  163. Verghese A., Roberson D., Kalbfleisch J. H., Sarubbi F. Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis. Antimicrob Agents Chemother. 1990 Jun;34(6):1041–1044. doi: 10.1128/aac.34.6.1041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  164. Verheul A. F., Snippe H., Poolman J. T. Meningococcal lipopolysaccharides: virulence factor and potential vaccine component. Microbiol Rev. 1993 Mar;57(1):34–49. doi: 10.1128/mr.57.1.34-49.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Vernham G. A., Crowther J. A. Acute myeloid leukaemia presenting with acute Branhamella catarrhalis epiglottitis. J Infect. 1993 Jan;26(1):93–95. doi: 10.1016/0163-4453(93)97096-g. [DOI] [PubMed] [Google Scholar]
  166. Virolainen A., Salo P., Jero J., Karma P., Eskola J., Leinonen M. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol. 1994 Nov;32(11):2667–2670. doi: 10.1128/jcm.32.11.2667-2670.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  167. Wald E. R., Reilly J. S., Casselbrant M., Ledesma-Medina J., Milmoe G. J., Bluestone C. D., Chiponis D. Treatment of acute maxillary sinusitis in childhood: a comparative study of amoxicillin and cefaclor. J Pediatr. 1984 Feb;104(2):297–302. doi: 10.1016/s0022-3476(84)81018-5. [DOI] [PubMed] [Google Scholar]
  168. Wallace M. R., Oldfield E. C., 3rd Moraxella (Branhamella) catarrhalis bacteremia. A case report and literature review. Arch Intern Med. 1990 Jun;150(6):1332–1334. [PubMed] [Google Scholar]
  169. Weiser J. N. The oligosaccharide of Haemophilus influenzae. Microb Pathog. 1992 Nov;13(5):335–342. doi: 10.1016/0882-4010(92)90077-2. [DOI] [PubMed] [Google Scholar]
  170. Weiss M. S., Abele U., Weckesser J., Welte W., Schiltz E., Schulz G. E. Molecular architecture and electrostatic properties of a bacterial porin. Science. 1991 Dec 13;254(5038):1627–1630. doi: 10.1126/science.1721242. [DOI] [PubMed] [Google Scholar]
  171. West M., Berk S. L., Smith J. K. Branhamella catarrhalis pneumonia. South Med J. 1982 Aug;75(8):1021–1023. doi: 10.1097/00007611-198208000-00029. [DOI] [PubMed] [Google Scholar]
  172. Wright P. W., Wallace R. J., Jr Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect. 1989 Mar;4(1):40–46. [PubMed] [Google Scholar]
  173. Yu R. H., Schryvers A. B. The interaction between human transferrin and transferrin binding protein 2 from Moraxella (Branhamella) catarrhalis differs from that of other human pathogens. Microb Pathog. 1993 Dec;15(6):433–445. doi: 10.1006/mpat.1993.1092. [DOI] [PubMed] [Google Scholar]
  174. von Graevenitz A., Rathbone R. R. Branhamella catarrhalis in respiratory secretions: clinical correlation in 16 cases. South Med J. 1981 Sep;74(9):1095–1096. doi: 10.1097/00007611-198109000-00021. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES